8-A837A-2017-Books-00129-029-060_Katz_Sec1_Ch02-ROUND-1

S E C T I O N I | T H Y R O I D

56

65. Solorzano CC, Carneiro DM, RamirezM, et al. Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg 2004;70:576–850; discussion 580–582. 66. Shimamoto K, Satake H, Sawaki A, et al. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 1998;29:4–10. 67. Stulak JM, Grant CS, Farley DR, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 2006;141:489–494; discussion 494–496. 68. Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003;134:946–954; discussion 954–955. 69. O’Connell K, Yen TW, Quiroz F, et al. The utility of routine preoperative cervical ultrasonogra- phy in patients undergoing thyroidectomy for differentiated thyroid cancer. Surgery 2013;154: 697–701; discussion 703. 70. Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 2007;92: 3590–3594. 71. Ahn JE, Lee JH, Yi JS, et al. Diagnostic accuracy of CT and ultrasonography for evaluating meta- static cervical lymph nodes in patients with thyroid cancer. World J Surg 2008;32:1552–1528. 72. Mulla M, Schulte KM. Central cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the central compartment. Clin Endocrinol (Oxf) 2012;76:131–136. 73. Hartl DM, Leboulleux S, Al Ghuzlan A, et al. Optimization of staging of the neckwith prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg 2012;255:777–783. 74. Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope 2011;121:487–491. 75. Deleted in production.. 76. Lang BH, Wong KP, Wan KY, et al. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papil- lary thyroid carcinoma. Ann Surg Oncol 2012;19:60–67. 77. Wang TS, Evans DB, Fareau GG, et al. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer. Ann Surg Oncol 2012;19:4217–4222. 78. American Thyroid Association Surgery Working G, American Association of Endocrine S, American Academy of O-H, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009;19:1153–1158. 79. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050–1057; discussion 1057–1058. 80. Shah MD, Hall FT, Eski SJ, et al. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope 2003;113:2102–2107. 81. Chiang FY, Wang LF, Huang YF, et al. Recurrent laryngeal nerve palsy after thyroidectomy with routine identification of the recurrent laryngeal nerve. Surgery 2005;137:342–347. 82. Gemsenjager E, Perren A, Seifert B, et al. Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg 2003;197:182–190. 83. Kouvaraki MA, Lee JE, Shapiro SE, et al. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 2004;136:1183–1191. 84. Hughes DT, Laird AM, Miller BS, et al. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann Surg Oncol 2012;19:2951–2957. 85. Moo TA, Umunna B, Kato M, et al. Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg 2009;250:403–408. 86. Koo BS, Choi EC, Yoon YH, et al. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg 2009;249:840–844. 87. Kim WW, Park HY, Jung JH. Surgical extent of central lymph node dissection in clinically node- negative papillary thyroid cancer. Head Neck 2013;35:1616–1620. 88. Scherl S, Mehra S, Clain J, et al. The effect of surgeon experience on the detection of metastatic lymph nodes in the central compartment and the pathologic features of clinically unapparent metastatic lymph nodes: what are we missing when we don’t perform a prophylactic dissec- tion of central compartment lymph nodes in papillary thyroid cancer? Thyroid 2014;24:1282– 1288.

•AQ6•